Xentuzumab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Xentuzumab, covering 2022-09-29 to 2025-06-25. Get the full timeline:
Most recent: Clinical Trial Update: Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) [Phase 1]